It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Aims
Cognitive impairment and functional status are both important determinants of poor outcomes in heart failure (HF). However, little is known about how functional status impacts the changes in cognitive status during the disease course. This study aimed to describe the cognitive transitions in patients with HF and assess the relationship of these transitions to functional status, which was assessed by the dependency of activities of daily living (ADL).
Methods and results
This retrospective cohort study included 1764 patients with an International Classification of Diseases‐10 code of HF (≥65 years, mean age 82.3 ± 7.9 years, 39% male) from a long‐term care and medical insurance database from Nobeoka city, a rural city of south‐western Japan. Cognitive status at baseline and 6, 12, 18, and 24 month time points was collected, and participants were stratified based on ADL status at baseline. Generalized estimating equations and multi‐state modelling were used to examine associations between ADL dependency and cognitive changes/mortality. Transition probabilities were estimated using multi‐state modelling. At baseline, there were 1279 (73%) and 485 (27%) patients with independent and dependent ADL, respectively. In overall patients, 1656 (93.9%) patients had normal/mild cognitive status and 108 (6%) patients had a moderate/severe cognitive status at baseline. The majority [104 (96%) patients] of patients with moderate/severe cognitive status at baseline had dependent ADL. In patients with moderate/severe cognitive status, the number of patients with dependent ADL always outnumbered that of the independent ADL throughout the follow‐up. Multi‐state modelling estimated that patients with dependent ADL and normal/mild cognitive status at baseline had 47% probability of maintaining the same cognitive status at 24 months, while the probability of maintaining the same cognitive status was 86% for those with independent ADL. Patients with normal/mild cognitive status in the dependent ADL group at baseline had a higher risk of experiencing a transition to moderate/severe cognitive status at any time point during 24 months compared with those with independent ADL [hazard ratio 5.24 (95% confidence interval 3.47–7.90)].
Conclusions
In older patients with HF, the prevalence of cognitive impairment was always higher for those with reduced functional status. Despite having a normal/mild cognitive status at baseline, patients with dependent ADL are at high risk of experiencing cognitive decline over 24 months with substantially less chance of maintaining their cognitive status. ADL dependency was an important risk factor of cognitive decline in patients with HF.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Takegami, Misa 2
; Teramoto, Kanako 3
; Murata, Shunsuke 4 ; Nakatsuka, Kiyomasa 5 ; Ogata, Soshiro 1 ; Nishimura, Kunihiro 1 1 Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan
2 Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan, Department of Public Health and Health Policy, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
3 Department of Biostatistics, National Cerebral and Cardiovascular Center, Suita, Japan
4 Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan, Department of Public Health, Graduate School of Health Sciences, Kobe University, Kobe, Japan, Japan Society for the Promotion of Science, Tokyo, Japan
5 Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, Suita, Japan, Department of Public Health, Graduate School of Health Sciences, Kobe University, Kobe, Japan





